π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This is a Phase 1b/2a, open-label, multi-center, dose-escalation and safety...
Status
Completed
Location
Site 2644 University of California, Irvine
Start Date
2018-06-19
Trial ID
NCT03294083
Treatments Being Tested
Phase I trial to compare the effectiveness of vaccine therapy with or witho...
Status
Terminated
Location
Lombardi Comprehensive Cancer Center at Georgetown University
Start Date
2000-11
Trial ID
NCT00009958
This is a neoadjuvant Phase 2a, open-label trial in patients with metastati...
Status
Terminated
Location
Ottawa Hospital and Research Institute (OHRI)
Start Date
2011-10
Trial ID
NCT01329809
Treatments Being Tested
Background: * Flutamide is an approved drug for prostate cancer that block...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-02-23
Trial ID
NCT00450463
Treatments Being Tested
RATIONALE: Vaccines made from a gene-modified virus may make the body build...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support
Start Date
2002-09
Trial ID
NCT00052351
Background: " Adenocarcinoma of the prostate is the most common cancer dia...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2003-05-22
Trial ID
NCT00060528
This is a Phase I, open-label, dose-escalation trial in patients with advan...
Status
Completed
Location
Billings Clinic
Start Date
2008-06
Trial ID
NCT00625456
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill mela...
Status
Unknown
Location
Kimmel Cancer Center of Thomas Jefferson University - Philadelphia
Start Date
1996-04
Trial ID
NCT00002817
Treatments Being Tested
This study is to determine how effectively JX-594 (Pexa-Vec) will prolong l...
Status
Completed
Location
Mayo Clinic
Start Date
2012-06
Trial ID
NCT01636284
Treatments Being Tested
Vaccines made from a gene-modified virus may help the body build an effecti...
Status
Completed
Location
Baptist Cancer Institute
Start Date
2006-02
Trial ID
NCT00108732